BSE Live
Mar 09, 16:01Prev. Close
2186.45
Open Price
2125.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 09, 15:55Prev. Close
2187.00
Open Price
2131.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2163.30 (295)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 09 | Mar 08 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 185.24 | 110.26 | |
| Net CashFlow From Operating Activities | 72.38 | 29.72 | |
| Net Cash Used In Investing Activities | -57.53 | -19.25 | |
| Net Cash Used From Financing Activities | -12.71 | 43.75 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 2.14 | 54.22 | |
| Cash And Cash Equivalents Begin of Year | 57.47 | 3.25 | |
| Cash And Cash Equivalents End Of Year | 59.61 | 57.47 |
17.02.2026
05.02.2026
Mankind Pharma Consolidated December 2025 Net Sales at Rs 3,567.20 crore, up 10.44% Y-o-Y
05.02.2026
Mankind Pharma Standalone December 2025 Net Sales at Rs 2,632.68 crore, up 9.85% Y-o-Y
04.02.2026
05.02.2026
Mankind Pharma Consolidated December 2025 Net Sales at Rs 3,567.20 crore, up 10.44% Y-o-Y
05.02.2026
Mankind Pharma Standalone December 2025 Net Sales at Rs 2,632.68 crore, up 9.85% Y-o-Y
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y